The healthcare conglomerate, based in New Brunswick, N.J., recently acquired hair care company Vogue International for $3.3 billion, according to The New York Times.
While Johnson & Johnson’s drug division thrives, the consumer goods section produces lower margins than rivals and the medical device division remains stagnant since 2010.
Last year, Artisan Partners tried to pressure Johnson & Johnson to split. As Artisan owned well under 1 percent of its stock, the shareholders lacked the power to sway the conglomerate and its $312 billion market value.
More articles on supply chain:
FDA issues final guidance over post-market surveillance for medical devices
These drug, device companies are offering money-back guarantees to hospitals, payers
Medical device sales drive Medtronic’s $1.1B net income in Q4
